0.76 USD
▲+0.04+5.15%
盘后 0.72 -0.98%
2026-08-03
市值
$5.62M
市盈率
—
EPS
-8.75
股息率
—
52 周区间
0.64 – 20.00
成交量
149.54K
Beta
3.66
目标价
10.00
52W 低 0.6452W 高 20.00
价格走势
公司简介
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine....